Munoz, Miguel. “Aprepitant, When Used With Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients With Breast Cancer: Aprepitant in Breast Cancer Outcomes”. Pakistan Journal of Health Sciences 7, no. 8 (August 31, 2026): 01–02. Accessed September 1, 2026. https://thejas.com.pk/index.php/pjhs/article/view/4537.